Krka, d.d., Novo Mesto
KRKG · LJSE · Pharmaceuticals
Tentang perusahaan
Krka is a Slovenian generic pharmaceutical company headquartered in Novo Mesto, ranked among the top 10 generic drug makers in Europe and 16th globally. The group generates revenues primarily from prescription generics, over-the-counter medicines, and veterinary products, with Eastern Europe representing its largest regional market. In 2024, group revenue reached approximately €1.9 billion, up 6% year-on-year, with a record operating profit of €408 million.
| Bursa | LJSE |
| Kode saham | KRKG |
| Sektor | Pharmaceuticals |
| Kapitalisasi pasar indikatif USD | $4.42B |
| Situs web | Kunjungi situs web |
Harga langsung
Memuat harga terkini…
| Kapitalisasi pasar | |
| Kisaran harian | |
| Kisaran 52 minggu |
Cara membeli
Di pasar asal (LJSE), dapat diakses melalui broker global yang menawarkan bursa tersebut:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Ljubljana Stock Exchange — pencatatan resmi di bursa
Hanya informasi ketersediaan — bukan rekomendasi atau penawaran untuk membeli. Konfirmasikan kelayakan, biaya, dan ketersediaan terkini dengan broker Anda.
Perusahaan lain di Slovenia
Data perusahaan dan harga langsung apa pun bersifat indikatif, mungkin tertunda atau tidak akurat, dan hanya untuk riset — bukan saran investasi. Verifikasi dengan bursa, pengajuan perusahaan, dan broker Anda.